Compass Therapeutics, Inc.
CMPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $484 | $360 | $263 | $198 |
| - Cash | $46 | $23 | $41 | $43 |
| + Debt | $0 | $10 | $6 | $7 |
| Enterprise Value | $438 | $347 | $228 | $161 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14 | -$21 | -$18 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$20 | -$17 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.14 | -0.12 | -0.11 |
| % Growth | 28.6% | -16.7% | -9.1% | – |
| Operating Cash Flow | $0 | -$12 | -$13 | -$9 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | -$12 | -$13 | -$9 |